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Angelica sinensis (AS) is a traditional Chinese herbal medicine that has been formulated clinically to treat various form of skin
traumaandtohelpwoundhealing.However,themechanismbywhichitworksremainsamystery.Inthisstudywehaveestablished
a new platform to evaluate the pharmacological eﬀects of total AS herbal extracts as well as its major active component, ferulic
acid(FA),usingproteomicandbiochemicalanalysis.Cytotoxicandproliferation-promotingconcentrationsofASethanolextracts
(AS extract) and FA were tested, and then the cell extracts were subject to 2D PAGE analysis. We found 51 diﬀerentially expressed
protein spots, and these were identiﬁed by mass spectrometry. Furthermore, biomolecular assays, involving collagen secretion,
migration,andROSmeasurements,gaveresultsthatareconsistentwiththeproteomicanalysis.Inthiswork,wehavedemonstrated
a whole range of pharmacological eﬀects associated with Angelica sinensis that might be beneﬁcial when developing a wound
healing pharmaceutical formulation for the herbal medicine.
1.Introduction
Angelica sinensis (AS), which is called Dang-Gui in Chinese,
has been used in medicine for more than two thousand years
in East Asia, including China, Japan, Korea, and India. In
the past, AS has been mostly used to treat gynecological
conditions and anemia [1, 2] or formulated with Radix
lithosperme as an aid to wound healing [3]. In recent
studies, AS has been shown to have multiple properties
including the regulation of the immune system [4]a n da s
antioxidant [5], antiinﬂammatory [6], anticancer [7]a n d
others. Components of AS have been identiﬁed and classiﬁed
into two groups; the essential oils and the water-soluble
ingredients[8].Ferulicacid(FA)isoneofthemostabundant
water-soluble ingredients in AS and has been reported to
be the active component of AS [9]. FA is prominent as a
ROS scavenger because its structure is capable of stabilizing
phenoxyl radical intermediates. Furthermore, FA is also able
to activate proteins like heme oxygenase-1 (HO-1), heat
shock protein 70 (HSP70), Erk ½, and Akt, which help cells
to respond to environmental stress [10, 11].
Herbal drugs are diﬃcult to analyze due to their com-
plexity and the presence of toxicity due to alkaloids. To avoid
these complications, the eﬀect of single active component
of herbs is often explored, and this single active component
represents the eﬀects of the total herb; examples are shikonin
forRadixlithosperme[12],andOridoninforIsodonrubescens
[13]. However, the disadvantage of this single component
approach is that the results can never be the same as the
complete biochemical and pharmacological mechanisms of
the total herb and may not reveal the real mechanism(s) of
the formulated traditional Chinese medicine.
Proteomics is a powerful tool and has been widely
used to elucidate protein proﬁle changes in response to
drug treatment and to identify disease-relevant biomarkers.
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was identiﬁed as contributing to the anti-hepatocellular
carcinoma eﬀect (HCC) of this traditional medicine using
HepG2 cells [14]. Similarly, a proteomic analysis on Uncaria
rhynchophylla (Miq) Jack and its major component rhyn-
chophylline was able to demonstrate an upregulation in the
expression of MIF and cyclophilin A in kainic acid-induced
epilepsy in rats [15].
Angelica sinensis (AS) is a basic component of many Chi-
nese drugs that are used for wound healing, for example,
shiunko [16]. Although AS has been applied in animal
models and clinically, the mechanism by which AS helps
wound healing remained to be clariﬁed. Therefore the
purpose of this study was to explore the mechanisms by
which an ethanol extract of AS exerts its protective eﬀect
on human skin ﬁbroblasts using both biochemical and
proteomicapproaches.Thisapproachalsoexploredtheeﬀect
of the drug’s active water-soluble component of FA. Based
on these ﬁndings, it should be possible to identify the
pharmacological eﬀects of AS and how these contribute
to the process of wound healing when treated with some
Chinese traditional herbal medicines that contain AS.
2.MaterialsandMethods
2.1. HPLC Analysis. The HPLC system was equipped with
BAS PM-80 pumps, a DGU-20A5 degasser, a CMA/170
autosampler, and a Varian (model 340) photodiode array
detector. Chromatographic separation was performed using
a Phenomenex Fusion RP-80 (2504.6mm, 4m). The mobile
phases were acetonitrile (solvent A) and 2% acetic acid
(solvent B). For the analysis of ferulic acid, the mobile phase
involved the following linear gradient: from 25% A to 75% A
in 0–15min at a ﬂow rate of 1.0mL/min, and the detection
wavelength was set on 280nm. The sample injection volume
was 20μL.
2.2. Cell Culture. Human embryonic skin ﬁbroblast was ob-
tained from Bioresource Collection and Research Center
(BCRC) no. 60118 (Detroit 551). Cells were cultured in
10cm culture dish (Corning) with minimum essential
mediumeagle(MEM)containing2mML-glutamine,1.5g/L
sodium bicarbonate, 0.1mM nonessential amino acids,
and 1.0mM sodium pyruvate (MEM alpha-modiﬁcations,
Sigma), supplemented with 10% fetal bovine serum (SAFC
Bioscience), 50 units/mL penicillin, 0.05mg/mL strepto-
mycin, and 0.1mg/mL neomycin (Sigma); the cells were
grown in a humidiﬁed atmosphere at 37◦C and 5% CO2.
For passage, when ﬁbroblasts had grown to a conﬂuence of
approximately 90% in the 10cm culture dish, medium was
discarded and the cells washed with 5mL PBS twice. They
were then harvested using 2mg/mL EDTA and 5mg/mL
trypsin in phosphate-buﬀered saline (PBS). After washing
with 5mL PBS twice, the cells were collected by centrifuga-
tion at 1300rpm for 5min. The supernatant was discarded
and the cells pipetted into fresh culture medium. They were
then aliquoted into several 10cm culture dishes.
2.3. Cell Viability Assay (WST-1 Assay). The cell viability
assay was performed according to the procedure described
in the manufacturer’s manual (Roche) with minor modiﬁ-
cations. This is a colorimetric assay for the quantiﬁcation of
cell proliferation based on the cleavage of the water-soluble
tetrazolium salt (WST-1) by mitochondrial dehydrogenases
in viable cells. Drug-treated cells were seeded at a concentra-
tion of 4 × 104 cells/well (about 40% conﬂuence) in 1mL
culture medium into a 24-well culture plate and incubated
at 37◦C in an incubator containing 5% CO2.A f t e rc e l l sh a d
attached, they were treated with 0.1% DMSO, 300μg/mL
AS extract, or 3.5μM FA for 24hr. The supernatant was
discarded and cell proliferation reagent WST-1 (Roche)
was added to each well at a 1:50 ratio with fresh culture
medium. The cells were then incubated for an additional
1hr in dark. The absorbance was measured at 450nm using
an ELISA reader (Thermo, Multiskan Spectrum), and the
absorbance of the background was measured at 690nm.
The diﬀerence in absorbance between 450nm and 690nm
indicates the relative cell viability compared to 0.1% DMSO.
The experiments were performed with three replicates for
each sample.
2.4. Sample Preparation for 2D PAGE. Fibroblasts were
washed twice in phosphate-buﬀered saline (PBS) and lysed
with 1mL of NP-40 lysis buﬀer containing 10mM Tris-
HCl (pH 7.5), 50mM NaCl, 1% NP-40, 30mM Na2P2O7,
30mM NaF, 1mM Na3VO4, 1% protease inhibitor, and
1% phosphatase inhibitor (Sigma). The whole cell lysate
was centrifuged at 14000rpm for 20min at 4◦Ct or e m o v e
insoluble material. The supernatant was transferred to a
concentrator (GE Health, vivaspin 20, 100k MWCO) and
centrifuged at 6000×g, 4◦C, until volume less than 500μL,
then the lysis buﬀer was replaced with dH2O containing 1%
protease inhibitor and 1% phosphatase inhibitor (Sigma).
The protein concentration was quantiﬁed by the Bradford
protein assay (Bio-Rad), and the samples were applied
directly for 2D PAGE analysis.
2.5. Analysis of the Protein Proﬁles Using 2D PAGE. The 2D
PAGE was performed according to the method described
in the manufacturer’s manual (Amersham Biosciences) with
minor modiﬁcations. For the ﬁrst-dimension IEF, pH 4–7,
IPG strips (18cm) were rehydrated with 400μLr e h y d r a t i o n
buﬀer (0.5% IPG buﬀer, 8M urea, 2% CHAPS, 50mM
dithiothreitol (DTT), and a trace of bromophenol blue) for
at least 4hr before 100μg of protein sample was loaded
by cup loading. IEF was then carried out under following
conditions: 150V for 5hr step and hold, 500V for 3hr step
and hold, 1000V for 7hr gradient, 8000V for 3hr gradient
and 8000V for 18hr step-and-hold. Prior to the second-
dimension SDS-PAGE, the IPG strips were equilibrated with
4mL of equilibration buﬀer, containing 50mM Tris-HCl
pH 8.8, 6M urea, 2% SDS, 30% glycerol, 50mM DTT, and
0.01% bromophenol blue at room temperature for 15min,
which was followed by equilibration in 50mM Tris-HCl pH
8.8, 6M urea, 2% SDS, 30% glycerol, 5% iodoacetamide,
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15min. The second-dimensional SDS-PAGE used a 12.5%
separating gel andwasperformedwithoutastacking gel.The
equilibratedIPGgelstripwasplacedontopoftheSDS-PAGE
with appropriate pressure to ensure a ﬁrm contact between
the strip and the gel slab. Electrophoresis was carried out at
35mA/gel until the tracking dye reached the bottom of the
gel. The 2D PAGE was then silver stained.
2.6. Fast Silver Staining. After 2D PAGE electrophoresis, the
gel was removed, immersed in ﬁx solution (40% methanol
and10%aceticacidindH2O)for10min,washedwithdH2O
for 10min twice, and then immersed in solution A (0.25mM
sodium thiosulfate) for 30min, which was then replaced by
dH2O for 10min. Next the gel was immersed in solution B
(3.5mM silver nitrate) for 30min. After rinsing with dH2O,
a mixture of solution C (0.357M) and solution D (4.37mM)
in dH2O were used to develop the protein spots on the 2D
PAGE gel. The reaction was stopped by 5% acetic acid.
2.7. Detection and Quantitative Analysis of the 2D PAGE Gels.
2D PAGE images were obtained, and the amount of protein
in each spot was analyzed using ImageMaster 2D Elite
softwareversion5.0(AmershamBiosciences).Thevolumeof
a protein spot was deﬁned as the sum of the intensities of the
pixelunitswithintheproteinspot.Tocorrectforquantitative
variationsintheintensityofproteinspots,spotvolumeswere
normalizedasapercentageofthetotalvolumeofallthespots
present in a given gel.
2.8. Protein Identiﬁcation by LC-MS/MS. The process is
described in a document from the Institute of Biologi-
calChemistry,AcademiaSinicaInstituteofBiologicalChem-
istry (http://proteome.sinica.edu.tw/) and this was used with
minor modiﬁcation. Selected silver-stained protein spots
were excised from the 2D PAGE. They were then de-silver-
stain using 1:1 Na2S2O( 0 . 1gi n1m LH 2O) and K6Fe(CN)6
(0.1g in 1mL H2O) in 25mM ammonium bicarbonate
until being transparent. Next the gel slices were added to
25mM ammonium bicarbonate pH 8.5 for 10min, vacuum-
dried, and rehydrated with 50% acetonitrile in 25mM
ammonium bicarbonate pH 8.5 at room temperature for
10min. The supernatant was then discarded and the sample
vacuum-dried. Subsequently, the protein within the spot was
trypsinized with 0.1% sequencing-grade modiﬁed trypsin
(Promega, Madison, WI, USA) in 25mM ammonium bicar-
bonate, pH 8.5, at 37◦C for at least 16hr. Each supernatant
was removed into a new Eppendorf tube, then 25mM
ammonium bicarbonate pH 8.5 was added to the previous
gel sample, and the mixture sonicated for 1min, 10 times.
The supernatant from this treatment was also removed into
a new Eppendorf tube. The process was repeated a third
time by adding 50% acetonitrile in 25mM ammonium
bicarbonate pH 8.5 to the sample, which was followed
by sonication for 1min, 10 times. The three extracted
supernatants were pooled and evaporated to dryness under
vacuum, and the dried pellet used to carry out integrated
nanoLC-MS/MS system (Micromass) (National Research
Program for Genomic Medicine, Academia Sinica). Eleven
rare diﬀerentially regulated protein spots were identiﬁed
by LC-MS/MS (Orbitrap) mass spectrometry system (Pro-
teomics Research Center, National Yang-Ming University) in
this way. The nanoLC-MS/MS data acquisition was carried
out by Micromass ProteinLynx Global Server (PGS) 2.0 data
processing software in a default mode and outputted as a
single Mascot-searchable peak list (.pkl) ﬁle. The LC-MS/MS
(Orbitrap) data were processed by SWQUEST (Thermo
Finnigan). The peak list ﬁles were used to query the Swiss-
Portversion2010 05databaseusingMascotprogramversion
2.2 (release date, 28-Feb-2007, Matrix Science, London, UK)
with the following parameters: a taxonomy of Homo sapiens
(20,400 sequences), peptide mass tolerance of 50ppm,
MS/MS ion mass tolerance of 0.25Da, trypsin digestion
with one missed cleavage, no ﬁxed modiﬁcation, and the
variable modiﬁcations considered were methionine oxida-
tion, cysteine carboxyamidomethylation, lysine acetylation
andphosphorylationoftyrosine,serine,andthreonine.Only
signiﬁcant hits as deﬁned by Mascot probability analysis
were considered. Protein identiﬁcations were accepted with
a statistically signiﬁcant Mascot protein search score ≥36 or
SEQUEST score = 2.5 (critical), which corresponds to an
error probability of P<0.05 using our data set. The protein
identiﬁcation with the highest scorewasselected to eliminate
protein redundancy within the database.
2.9. Cluster Analysis and Functional Classiﬁcation of the Dif-
ferentially Expressed Proteins. A plot of the calibrated inten-
sity for the expression value of each protein as measured
by ImageMaster 2D Elite software version 5.0 (Amersham
Biosciences, Sweden) among the diﬀerent groups of samples
was used in conjunction with an average linkage hierarchical
clustering algorithm (UPGMA, Unweighted Pair Group
Method with Arithmetic Mean); this was done using Hierar-
chicalClusteringExplorer3.5[17].TheuncenteredPearson’s
correlation coeﬃcient was determined as a measurement of
the similarity metric, and the threshold value for the mini-
mum similarity was set at 0.8. After clustering, each protein
wasallocateditsplaceinaglobaltemporalclassiﬁcationcolor
heatmap.WeusedBGSSJ(BulkGeneSearchSystemforJava;
http://bgssj.sourceforge.net/)[17]andtheSwiss-Protprotein
knowledge database for the functional classiﬁcation of the
proteins.
2.10. Western Blotting. Proteins extracts from ﬁbroblast cells
(Detroit 551) were separated by 12.5% SDS-PAGE and then
transferred onto a nitrocellulose (NC) membrane. The NC
membrane was blocked with 5% nonfat milk in TBST
at room temperature for 1hr and probed with various
primary antibodies (anti-p-Erk1/2 (no. 9101), 1:2000; anti-
Erk1/2 (no. 9102), 1:1000; anti-p-Akt (no. 9271), 1:1000
and anti-Akt (no. 9272), 1:1000, Cell Signaling; anti-TGF-
β (sc-52829), 1:1000, Santa Cruz; anti-β-tubulin (T4026),
1:5000, Sigma Aldrich; anti-HSPB1 (ab39399), 1:1000
and anti-STMN (cb1047), 1:1000, Abcam; anti-GSTP1
(GTX112953),1:3000andanti-TPIS(GTX104618),1:3000,
GeneTax) in 5% BSA or non-fat milk in TBST. After
washing the NC membrane, the NC membrane was treated4 Evidence-Based Complementary and Alternative Medicine
with HRP-conjugated secondary antibody. The bands were
visualizedbychemiluminescenceusingachemiluminescence
imaging system (LAS-4000, Fujiﬁlm) and performed den-
sitometric analysis using Fujiﬁlm MultiGauge software ver.
2.0. The results are expressed as mean ± standard deviation.
Student’s t-test was used to evaluate statistical signiﬁcance,
and a P value <0.05 was regarded as statistical signiﬁcant
(n = 4f o re a c he x p e r i m e n t ) .
2.11. Intracellular ROS (Reactive Oxygen Species) Assay. To
measure the ROS content of the ﬁbroblasts after DMSO,
AS extract, or FA treatment, the intracellular content of
H2O2, which is in proportion to ROS, was determined using
the redox-sensitive ﬂuorescent dye 2 ,7 -dichloroﬂuorescein
diacetate (DCF-DA) (Sigma). Brieﬂy, cells were cultured
to conﬂuence and trypsinized. After centrifugation, discard
supernatant and the cells were resuspended and incubated
with 10μM DCF-DA (20mM in DMSO for stock solution
a n ds t o r e di n−20◦C), which solved in 1 × PBS for 10
minutes at 37◦C in the dark. Centrifuge again and cells
were then washed and resuspended in fresh culture medium.
At o t a lo f8× 104 cells were added to a black ﬂat 96-
well ELISA plate with 200μLo fm e d i u m .R O Si sa b l et o
oxidize DCF-DA to the ﬂuorescent DCF, and therefore the
relativeconcentrationofintracellularROSisdeterminedbya
ﬂuorescence reader using excitation at 485nm and emission
at 538nm. Student’s t-test was used to evaluate statistical
signiﬁcance, and a P value < 0.05 was regarded as statistical
signiﬁcant (n = 3f o re a c he x p e r i m e n t ) .
2.12. Boyden Chamber Migration Assay. After cells were
cultured to conﬂuence, they were trypsinized, centrifuged,
and resuspended in culture medium. A total of 2 × 104
ﬁbroblasts were seeded in a Transwell (24 well, Corning) and
treatedwithDMSO,ASextract,orFA;theTranswellwasthen
inserted in culture medium without bubbles. After 6hr, the
Transwell was removed from the culture medium and the
cellsﬁxedusingmethanolfor10min.Themethanolwasthen
discardedandthecellsair-dried.Finallythecellswerestained
with 5% Giemsa (solved in dH2O) in room temperature
overnight. The Transwell was washed with dH2O, and the
inner cells on the Transwell were removed by scraping with a
cotton swab. The number of cells migrated down through
the Transwell was manually counted under microscope.
Student’s t-test was used to evaluate statistical signiﬁcances,
and a P value <0.05 was regarded as statistical signiﬁcant
(n = 3f o re a c he x p e r i m e n t ) .
2.13. Wound Healing Assay. A total of 2.5 × 104 ﬁbroblasts
were seeded onto both sides of a culture insert (ibidi) in a
24-well plate to generate 500μm ± 50μm gap between the
cell layers before drug treatment. After the cells had attached,
the culture insert was removed carefully. The cells were then
treated with the various drugs, which were added to the
culture medium. The cells were then incubated for 24hr.
The medium was then discarded and the cells washed twice
with PBS to remove unattached cells. Photographs were then
takenbydigitalcamerausingmicroscopy(Olympus)andthe
sizeofthegapmeasured.Student’st-testwasusedtoevaluate
statistical signiﬁcances, and a P value < 0.05 was regarded as
statistical signiﬁcant (n = 3f o re a c he x p e r i m e n t ) .
2.14. Sircol Collagen Assay. The process is described in Sircol
collagen assay general protocol (Biocolor). In brief, 3mL cell
medium was collected after drug treatment, and collagen
was precipitated by 4M NaCl to avoid FBS interference. The
collagen pellet was collected by centrifugation at 15000×gi n
room temperature, and the pellet was dissolved in 0.5mL of
0.5M acetic acid. 1mL of Sircol dye reagent was mixed with
100μL resolved collagen sample and then gently inverted at
room temperature for 30min. The resulting collagen was
collected then centrifugation at 10000×g for 10min. The
pellet was dissolved in 1mL alkali reagent by vortexing and
the collagen concentration was determined by a spectropho-
tometer at OD540. Student’s t-test was used to evaluate
statistical signiﬁcances, and a P value < 0.05 was regarded
as statistical signiﬁcant (n = 3f o re a c he x p e r i m e n t ) .
3. Results
3.1. Safety and Eﬃcacy Analysis of AS Ethanol Extracts and FA
Treatment. I no r d e rt oe s t a b l i s ham o d e ls y s t e mt oa n a l y z e
the eﬃcacy of total herbal extracts, we used Angelica sinensis
ethanol extracts (AS extract) and its active component,
ferulic acid (FA), as samples. AS was extracted using absolute
ethanol and then analyzed by HPLC to determine the
quantity of FA in the AS extract.The concentration of FA in
the AS extract (see Figure 1 in the supplementary material
available at doi:10.1155/2012/467531) was 2.278mg/mL.
Traditionally, AS is a common basic component when for-
mulating Chinese herbal medicines for wound healing, and
therefore we used human skin ﬁbroblasts as an experimental
cell model to elucidate the underlying mechanisms by which
AS aids with the process of wound healing. AS extract and
FA were dissolved in DMSO to give concentrations ranging
from 10 to 500μg/mL and 1 to 200μM, respectively, in
order to determine the optimal drug concentrations for
ﬁbroblast cell growth. As shown in Figure 1,A Se x t ra c t sw e r e
able to signiﬁcantly enhance cell viability by up to 125%
in a dose-dependent manner (Figure 1(a)), but FA had no
obvious eﬀect on cell growth (Figure 1(b)). It was noted
that 500μg/mL of AS extract was the highest concentration
that was still able to help cell growth, and concentration
beyond this point inhibited cell growth. Based on these
observations,wechose300μg/mLofASextractforthisstudy
in order avoid any complicated pharmacological eﬀects.
Correspondingly, the appropriate concentration of FA based
on the level in the AS extract was 3.5μM. Noticeably, AS
extract signiﬁcantly promotes cell growth, but the active
component FA is not able to induce a similar eﬀect.
This conﬁrms that the pharmacological eﬀect of a single
c o m p o n e n to fa nh e r bp l a n ti sn o te q u i v a l e n tt ot h a to fa
whole extract from the same plant in this case.Evidence-Based Complementary and Alternative Medicine 5
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Figure 1: Eﬀects of AS extract or FA on cell viability after 24hr treatment in human ﬁbroblast. Graph represents the ratio of cell viability
compared with the DMSO control. (a) AS extract promotes cell growth in a dose dependent manner up to 400μg/mL, but FA treatment (b)
hasnosigniﬁcanteﬀectoncellproliferation.Fibroblastswereseededina24wellplatewith4 ×104 cellsperwell.Afterthecellswereattached,
diﬀerent drug concentrations were added for 24hr and cell proliferation was evaluated by WST-1 assay at OD450−OD690. The control was
treated with 0.1% DMSO only. The Student’s t test was used to evaluate the statistical signiﬁcance of the results, which are presented as mean
±SD (n = 5). ∗P<0.05, ∗∗P<0.01, compared with the control.
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Figure 2: Diﬀerential eﬀect of AS and FA treatment on human ﬁbroblasts as visualized by 2D PAGE. 300μg/mL AS extract and 3.5μMF A
were used to treat cells for 24hr. Whole-cell lysates were extracted and analyzed by 2D PAGE (ﬁrst dimension, 18cm, pH 4–7, nonlinear
gradient of IPG strips; second dimension, 12.5% SDS-PAGE) and visualized by silver staining. There were 29 and 22 diﬀerentially expressed
spots that could be identiﬁed from the AS extract and FA-treated cells, respectively, compared with the DMSO control. The numbered
protein spots were identiﬁed by LC-MS/MS mass spectrometry. The corresponding protein spot identities are shown in Table 1.
3.2. 2D PAGE Protein Proﬁling and the Identiﬁcation of Diﬀer-
entially Expressed Protein Spots from Fibroblast Cells Treated
withDMSO,ASExtract,orFA. TofurtherinvestigatehowAS
extract and its active component FA can aﬀect the processes
of wound healing of the injured skin, two-dimensional (2D)
PAGE was then carried out. In this study, 0.1% DMSO,
300μg/mL AS extract, or 3.5μM FA-treated cell lysates were
separated by 2D PAGE and visualized by silver staining. The
stained 2D PAGE gels were then analyzed by Image Master
5.0. This software identiﬁed proteins showing quantitatively
diﬀerent expression levels on the 2D PAGE gels using the
DMSO treated cells as reference. As shown in Figure 2,w e
were able to identify 29 and 22 protein spots for AS and FA
respectively that were signiﬁcantly increased or decreased by
more than 1.5- or 0.67-fold in intensity in response to AS
extract, or FA treatment compared to DMSO, respectively.
These protein spots were numerically labeled and are shown
in Figure 2.
To further characterize these diﬀerentially expressed pro-
teins, the concentration of total protein lysate was increased
to more than 1mg, which was followed by 2D PAGE and
staining with Coomassie blue. Forty abundant diﬀerentially
regulatedproteinspotswereidentiﬁableonthis2DPAGEgel,
and these were excised and analyzed by LC-MS/MS (Q-TOF)6 Evidence-Based Complementary and Alternative Medicine
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mass spectrometry. In addition, eleven rare diﬀerentially
regulated protein spots were excised from the earlier silver
stained 2D PAGE gel and analyzed by the more sensitive
LC-MS/MS (Orbitrap) mass spectrometry. The resulting
peptides were screened using the Mascot database online
search engine and SEQUEST to identify the proteins. The
detailed results of the protein identiﬁcation are presented in
Table 1 using the DMSO treatment as reference. A Mascot
score 36 or a SEQUEST score = 2.5 (critical) indicates
signiﬁcant protein homology (P<0.05). As shown in
Figure 2,29and22diﬀerentiallyexpressedproteinspotswere
characterizedfromthecellextractstreatedwithASextractor
FA, respectively.
3.3. Functional Classiﬁcation of the Diﬀerentially Displayed
Proteins. Bioinformatic tools were used to categorize the
diﬀerentially expressed proteins. All of the parameters of
the proteins identiﬁed by mass spectrometry (Table 1), such
as protein ID and ratio of protein expression levels, were
introduced into HCE 3.5 (Hierarchical Clustering Explorer),
which has been widely used for genomic or proteomic data
mining and pinpointing hidden meaningful results [17, 18].
Based on the expression level ratios of the protein spots
after the various treatments (AS extract/DMSO; FA/DMSO,
Table 1), it was possible to categorized 34 protein spots into
ﬁve clusters (Figure 3). In cluster A, the 13 protein spots are
all upregulated in ﬁbroblasts on treatment with either AS
extractorFA.InclusterB,the8proteinspotsareupregulated
in ﬁbroblasts treated with AS extract, but the expression
levels of these protein spots are not signiﬁcantly changed
upon treatment with FA. Five protein spots make up cluster
C,andtheseareonlyoverexpressedinﬁbroblaststreatedwith
FA. In cluster D, 5 protein spots are downregulated when
the ﬁbroblasts was treated with AS extract, but there is no
change in the expression level on treatment with FA. Only
3 protein spots form cluster E, and these are downregulated
upon treatment with either AS extract or FA. It is worth
notingthat,exceptinclustersAandE,theproteinexpression
isdiﬀerentwhencellsaretreatedwitheitherASextractorFA.
After clustering, we use NCBI PubMed and BGSSJ (Bulk
Gene Search System for Java) with the Swiss-Port database
to classify the biological functions of these proteins. The
delineated protein functions included protein transport,
protein metabolism, calcium ion binding, oxidoreductase
activity, antiapoptosis, protein binding, metabolism, signal
transduction, cell mobility, and cell growth.
Interestingly, seven oxidation-related proteins were
found among these diﬀerentially expressed proteins. Among
them, ﬁve oxidation-related proteins were found to be
upregulated in ﬁbroblasts when treated with either AS
extract or FA. These proteins were peroxiredoxin (PRDX)
2, PRDX4, PRDX6, glutathione S-transferase Pi (GSTP1),
and Parkinson’s disease protein 7 (PARK7) (Figure 3,c l u s t e r
A). The other two oxidation related proteins, glutaredoxin-
3 (GLRX3) and ferritin light chain (FRIL), were only up
regulated in cells treated with FA (Figure 3, cluster C).
The protein expression patterns of these proteins imply
that FA alone might exert greater antioxidative ability on
the ﬁbroblasts than AS extract. Furthermore, four of the
identiﬁed proteins were involved in the regulation of cell
growth or antiapoptosis, namely, translationally controlled
tumor protein (TCTP), heat shock protein beta-1 (HSPB1),
GSTP1 (bifunctional protein), and calpain small subunit 1
(CAPNS1) (Figure 3, clusters A and B). TCTP was upreg-
ulated in ﬁbroblasts treated with either AS extract or FA
(Figure 3, cluster A). In contrast, HSPB1, GSTP1, and
CAPNS1 were upregulated only in cells treated with AS
extract (Figure 3, cluster B). This suggests that AS extract
has a greater eﬀect on cell survival compared to FA. These
bioinformatic ﬁndings are consistent with the results from
the WST-1 cell growth test (Figure 1).
Calcium ions are very important in the regulation of
wound healing process, and its function is to modulate the
expression of genes involved in cell growth, diﬀerentiation,
attachment, motility, and collagen secretion [19]. Some
proteins related to the above functions were identiﬁed in this
study. Expression of annexin A2 (ANXA2) was upregulated
in ﬁbroblasts when treated with either AS extract or FA
(Figure 3,c l u s t e rA ) ;h o w e v e r ,a n n e x i nA 5( A N X A 5 )w a s
only upregulated when the cells were treated with FA
(Figure 3, cluster C). In contrast, synaptic vesicle membrane
protein VAT-1 homolog (VAT1) was only upregulated in
cells treated with AS extract (Figure 3, cluster B), while
triosephosphate isomerase (TPIS) was upregulated in cells
treated with either AS extract or FA. Furthermore, phos-
phoglycerate kinase 1 (PGK1) and L-lactate dehydrogenase B
chain (LDHB) were only upregulated in cells treated with AS
extract. During the wound healing process, cells are hypoxic
[20] and cell proliferation consumes a lot of energy in order
to repair the injured tissue. TPIS and PGK1 are important to
glycolysis, and LDHB catalyzes the generation of lactate by
the reduction of pyruvate. Overexpression of these proteins
would seem to provide additional energy resource allowing
the cells to survive under stress.
A number of motility-associated proteins were also iden-
tiﬁed. Actin-related protein 2/3 complex subunit 5 (ARPC5)
andstathmin(STMN1)wereonlyupregulatedincellstreated
with FA (Figure 3, cluster C), while vimentin (VIME) was
only downregulated in cells treated with AS extract (Figure 3,
cluster D). Surprisingly, NDKB and MARE1 were down-
regulated in cells after both treatments (Figure 3,c l u s t e r
E). These results suggest that treatment of ﬁbroblasts with
either AS extract or FA improves the ability of the cell to
survive under environmental stresses. With the exception of
VIME(formobility),treatmentofﬁbroblastswithASextract
modulates the upregulation of proteins that are associated
with cell growth (LEG1, CAPNS1), metabolism (PGK1,
LDHB), calcium ion regulation (VAT1), and antiapoptosis
(HSPB1). On the other hand, FA may have the unique
ability (Figure 3, cluster C) to modulate the upregulation
of proteins associated with cell mobility (STMN1, ARPC5),
antioxidativefunctions(GLRX3,FRIL),andcalciumionreg-
ulation (ANXA5). Interestingly, we found some overlapping
of proteins induced by either AS extract or FA treatment.
Two proteins associated with cell mobility (MARE1, NDKB,
Figure 3, cluster E) are down-regulated when ﬁbroblasts are
treated with either AS extract or FA. In contrast, some
proteins associated with metabolism (TPIS), antioxidative8 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Hierarchical clustering and functional classiﬁcation of the changes in protein expression between the DMSO control cells and
AS/FA-treated cells. The expression pattern for each protein was categorized by UPGMA using Hierarchical Clustering Explorer 3.5. Proteins
with a similar expression clustered into ﬁve diﬀerent discrete groups (clusters A, B, C, D, and E) in a tree-like organization. Each row in the
color heat map indicates a single protein and each column represents diﬀerent groups of proteins from the DMSO, AS, and FA treatments. A
high protein expression value for a speciﬁc protein spot is represented by a bright red color, and a low protein expression value is represented
by a bright green color. A black color indicates that the protein spot was expressed at an average level. A gray color represents protein spots
that were undetectable. Further information about the diﬀerentially expressed protein spots that were identiﬁed is given in Table 1.T h e
functional classiﬁcation of each protein was determined using BGSSJ and the Swiss-Prot protein sequence database.
functions (PRDXs, PARK7), antiapoptosis (GSTP1, TCTP),
and calcium ion regulation (ANXA2) are upregulated when
ﬁbroblasts are treated with either AS extract or FA (Figure 3,
cluster A).
3.4. Conﬁrmation of the Diﬀerential Expression of the Various
Proteins Detected by Proteomics Analysis. Western blot anal-
ysis was used to conﬁrm the changes in protein expression
detected by the proteomic approach. Human skin ﬁbroblasts
were seeded into plates and then treated with either AS
extract or FA for 24hr; then cell lysates were prepared as
indicatedinMaterialsandMethods.AsshowninFigures4(a)
and 4(b), expression of GSTP1 and TPIS (Figure 3,c l u s t e r
A) were upregulated in ﬁbroblasts after treatment with eitherEvidence-Based Complementary and Alternative Medicine 9
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Figure 4: Analysis of the results of 2D PAGE by immunoblotting and ROS assay. According to hierarchical clustering and functional
classiﬁcation, the expressions of GSTP1 and TPIS were both increased in 300μg/mL AS extract and 3.5μM FA-treated cells. In addition,
STMNexpressionincreasedinAS-extract-treatedcells,andHSPB1expressionincreasedin FAtreatedcells. GSTP1expression wasexamined
byimmunoblotting(a)usinganti-GSTP1antibodyandtheseresultswerethenfurtherconﬁrmedbyfunctionalROSassay(e).Theexpression
of TPIS (b), HSBP1 (c), and STMN (d) were also conﬁrmed by immunoblotting using speciﬁc antibodies. In all cases the results correlated
with the clustering and functional classiﬁcation of 2D PAGE. β-Tubulin was employed as the sample loading control. The relative expression
levels were detected by Fujiﬁlm Multigauge ver. 2.0 for densitometric analysis and normalized with internal control, and a Student’s t test
was performed to evaluate the statistical signiﬁcance. Results are presented as mean ± SD (n = 3). ∗P<0.01, #P<0.1 but with a decreased
trend compared with DMSO.
AS extract or FA, which is consistent with our proteomic
analysis (Figure 3 and Table 1). HSBP1 (Figure 3,c l u s t e rB )
was signiﬁcantly upregulated in ﬁbroblasts after AS extract
treatment, but FA treatment did not signiﬁcantly change
expression of this gene (Figure 4(c)). Furthermore, STMN1
was only signiﬁcantly upregulated in cells treated with FA
and no such change was detected when the cells were treated
with AS (Figure 4(d)); this also agrees with the proteomic
analysis (Figure 3, cluster C). Thus western blot analysis of
selected proteins is in agreement with the expression pattern
of the proteins as detected by our 2D PAGE and mass
spectrometry analysis (Figure 3), which provides validation
of our approaches.
3.5. Redox State of the Fibroblast after Treatment with AS
Extract and FA. The PRDX family of proteins and GSTP1
act as antioxidants [21], and these proteins show the greatest
increase in expression in response to treatment with AS
extract or FA (Table 1). These results seem to indicate that
the increase in these proteins may help to change the redox
state of the cells after drug treatment. The redox-sensitive
ﬂuorescent dye 2 ,7 -dichloroﬂuorescein diacetate (DCF-
DA) was used to measure the redox state of cells after drug
treatment. As shown in Figure 4(e), the ROS level of cells
treated with AS extract was signiﬁcantly reduced by 8%, but
this did not occur when the cells were treated with FA. It is
w o r t hn o t i n gt h a tF Ai sa ne ﬀective ROS scavenger due to10 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Functional conﬁrmation of the eﬀects of AS and FA treatment on human ﬁbroblasts. (a) Collagen secretion was signiﬁcantly
increased after AS extract treatment. After cells were seeded in a 24 well plate and treated with 0.1% DMSO, 300μg/mL AS extract or 3.5μM
FA for 24hr, the medium were collected to analyze the collagen concentration. The graph represents the ratio of collagen secretion compared
to the DMSO control. (b) Fibroblast migration is promoted after treatment with AS extract or FA. A total of 2 × 104 cells were seeded into
the top of Boyden chamber with 0.1% DMSO, 300μg/mL AS extract or 3.5μM FA and added fresh culture medium into the bottom. After
6hr, the cells were stained by 5% Giemsa dissolved in water and the upper cells on Boyden chamber were scraped with cotton swabs then the
cells counted using an inverted microscope. (c) TGF-β expression was increased after AS extract treatment and was correlated with collagen
s e c r e t i o n( a ) .At o t a lo f1× 106 ﬁbroblasts were seeded onto a 10cm culture dish and then treated with DMSO, 300μg/mL AS extract
or 3.5μM FA for 24hr. After washing with 1 × PBS, the cells were lysed by NP-40 lysis buﬀer with protease and phosphatase inhibitor.
TGF-β expression was determined by immunoblotting. The expression of phospho-Akt (d) and phospho-Erk (e) were also examined by
immunoblotting and it was found that AS extract was able to signiﬁcantly increase expression of these proteins. The relative expression levels
were detected by Fujiﬁlm Multigauge software and normalized with β-tubulin. The results are expressed as mean ± SD (n = 3). ∗P<0.05,
∗∗P<0.01, compared with the control.
its structure [11]; nonetheless, it would seem that FA alone is
notcompletelyeﬀectiveintermsofantioxidantactivity.Thus
some component(s) from the AS extract may be necessary,
togetherwithFA,toobtainmaximum anti-oxidative activity.
3.6. Functional Conﬁrmation of the Eﬀect of AS Extract on
Collagen Secretion and Migration. Collagen secretion and
crosslinking are the most important step when repairing
wounded tissue and collagen synthesis is controlled by
transforming growth factor beta (TGF-β), which is secreted
by macrophages and ﬁbroblasts [22]. Thus the eﬀect of AS
extract and FA on the secretion of collagen by ﬁbroblasts was
examined. As shown in Figure 5(a),A Se x t r a c tw a sa b l et o
signiﬁcantly promote collagen secretion by ﬁbroblasts and
the increase was up to 5% compared to the control; in
contrast, FA did not increase collagen secretion. Expression
of TGF-β was also analyzed by Western blotting, and it was
found that expression of TGF-β in response to treatment
with either AS extract or FA correlated with the results of the
collagen secretion assay (Figure 5(c)).
The functions of STMN1, ARPC5, NDKB, and MARE1
are known to be associated with cell mobility and wound
healing [23–26]; however, the expression levels of these
proteins, as detected by our proteomic analysis, varied, and
they grouped into diﬀerent clusters (Figure 3,c l u s t e rC ,D ,
E) in response to drug treatment. In these circumstances it
is important to clarify the eﬀects of each treatment on the
ﬁbroblasts, and therefore cell migration and wound healing
assays were carried out on cells treated with either AS extract
or FA. The Transwell assay was used for the cell migration
test. As shown in Figure 5(b), we found that both AS extract
andFAseemedtopromotecellmigrationtothesamedegree.
Furthermore, both AS extract and FA had the same eﬀect on
the promotion of ﬁbroblast wound healing (supplementary
Figure 2). These results suggest that FA might be the majorEvidence-Based Complementary and Alternative Medicine 11
active component in AS extract that promotes cell migration
and wound healing.
Only CAPNS1 is involved in cell growth based on the
proteomic classiﬁcation (Figure 3, cluster B). Phosphory-
lated Akt and Erk are known to be the factors that are
involved in promoting cell growth, and therefore experi-
ments were performed to measure the expression of these
two factors in ﬁbroblasts after treatment with either AS
extract or FA. As shown in Figures 5(d) and 5(e), the
expression levels of p-Akt and p-Erk were only upregulated
in ﬁbroblasts treated with AS extract. These results are
consistent with our cell viability assay, which shows that
ﬁbroblast cell growth is increased by about 25% when
ﬁbroblastsaretreatedwithASextracts,butthisdidnotoccur
when the cells are treated with FA (Figure 1). These ﬁndings
indicate that cell growth promotion is initiated by AS extract
treatment and this is likely to involve upregulation of the Akt
and Erk pathway in the treated ﬁbroblast cell.
4. Discussion
The cell viability test revealed that AS extract was able to
eﬀectively promote human skin ﬁbroblast proliferation with
low levels of cytotoxicity even at high concentrations. It is
wellknownthatskinﬁbroblastsplayanimportantroleinthe
proliferation phase of wound healing [27, 28], and therefore
treatment with AS extract would seem to have beneﬁcial
eﬀectsonﬁbroblastgrowth.Ithasbeenfoundpreviouslythat
functionallyrelatedproteinsareoftencoordinatelyexpressed
[29]. In agreement with this hypothesis, ﬁve clusters of
proteins were identiﬁed using 2D PAGE analysis with similar
changes in cellular expression level in terms of AS/FA
treatments.
4.1. Proteins Involved in Antioxidative Activity. ROS plays an
important role in the early phase of wound healing [30],
but excessive ROS in the wounded region is also harmful
to nearby normal cells. Peroxiredoxins (PRDXs), Parkinson’s
disease protein 7 (PARK7), and glutathione S-transferase
Pi (GSTP1) were categorized as cluster A proteins that
are upregulated in ﬁbroblasts by either AS extract or FA
(Figure 3, cluster A). PRDXs are a family of multifunctional
antioxidant thioredoxin-dependent peroxidases that protect
cells from hydrogen peroxide [31, 32]. The PRDXs family
consists of six members, and three of these (PRDx2, PRDX4,
and PRDX6) were identiﬁed as upregulated in this study.
PARK7 acts as a coordinator and induces the expression
of antioxidant genes such as glutamate cysteine ligase and
glutathione [33]. GSTP1 is a multifunctional protein that
can reduce hydroperoxides, carry out detoxiﬁcation, and
inhibit JNK phosphorylation; the latter results in a decrease
apoptotic cell numbers [34]. The mass spectrometry analysis
indicated that PRDX-2, PDRX-4, PDRX-6, and PARK7 were
identiﬁed in our sample (Table 1) with lower sequence
coverage. Nevertheless, the amount of hydrogen peroxide
in the ﬁbroblasts after AS extract treatment was substan-
tially reduced (Figure 4(e)), which indicates the presence
of antioxidants in cells after drug treatment. Furthermore,
GSTP1 was signiﬁcantly upregulated in ﬁbroblasts that had
been treated with either AS extract or FA (Figure 4(a)).
Together our results reveal that ROS was indeed signiﬁcantly
decreased in cells after AS extract or FA treatment and that it
islikelythatPRDX-2,PDRX-4,PDRX-6,PARK7,andGSTP1
are involved in this process.
4.2. Proteins Involved in the Regulation of Apoptosis. TCTP (a
translationally controlled tumor protein also named fortilin)
and GSTP1 are upregulated by treatment with either AS
e x t r a c to rF A( Figure 3, cluster A); additionally, AS extract
but not FA is able to induce heat shock protein beta 1
(HSPB1)expression(Figure 3,clusterB;Figure 4(c)).TheN-
terminus of TCTP is able to interact with Bcl-xL and help
the cell to avoid apoptosis; in contrast, downregulation of
TCTP expression increases the number of apoptotic cells
[35, 36]. It has also been reported that down-regulation
of GSTP1 results in an increase of c-Jun NH2-terminal
kinase-mediated apoptosis [37, 38]. HSPB1 (HSP27) works
as chaperone and helps protein folding; alternatively, it
can activate the proteasome allowing it to interact with
denatured proteins [39]. Phosphorylated HSPB1 is able to
inhibit the interaction of Daxx with Fas or ASK1, which
decreases the activation of downstream apoptosis-related
proteins [40]. Furthermore, wound closure is delayed in
knock-down SW480 cells indicating the involvement of
HSPB1 in regulating cell mobility [41]. Our results seem
to demonstrate that AS extract and FA may activate anti-
apoptosis in cells by upregulating the expression of TCTP
and GSTP1. Moreover, AS extract but not FA may have the
additional function of inhibiting apoptosis and regulating
cell mobility during the wound healing process via upregula-
tion of HSPB1.
4.3. Proteins Involved in the Regulation of Calcium Ion or Pro-
tein Transportation. Calcium ions play an important role in
w o u n dh e a l i n g ,c e l lp r o l i f e r a t i o n ,d i ﬀerentiation, adhesion,
migration, and collagen secretion [19]. Annexins are mem-
brane proteins that contain the annexin core domain and a
conserved calcium-lipid binding module that is involved in
calcium ion regulation. In addition, expression of annexin
A2 has been observed to be increased in migrating intestinal
epithelial cells [42]. In this study it was found that annexin
A2 was upregulated in ﬁbroblasts treated with either AS
extract or FA (Figure 3,c l u s t e rA ) .M o r e o v e r ,as y n a p t i c
vesicle membrane protein VAT-1 homolog (VAT-1) also is
known to participate in regulating calcium ion ﬂux [43]. We
found that treatment with AS extract but not with FA was
able to induce the upregulation of VAT-1 (Figure 3,c l u s t e r
B). Interestingly, our biochemical assays further indicated
that collagen secretion as well as the expression of TGF-
β is substantially increased in ﬁbroblasts after AS extract
treatment but not FA treatment (Figures 5(a) and 5(e)).
Therefore we propose that AS extract has a greater capacity
than FA to aﬀe c tc a l c i u mi o nr e g u l a t i o na sw e l la sa n yr e l a t e d
wound recovery eﬀects.12 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Summary of the eﬀects of the AS and FA treatments on human skin ﬁbroblasts.
4.4. Proteins Involved in Cell Mobility. Cell mobility is an
important part of the wound healing process [28]. Nucleo-
side diphosphate kinases B (NDKB) and microtubule associ-
ated protein RP/EB family member 1 (MARE1) were both
down-regulated in cells treated with either AS extract or
FA (Figure 3, cluster E). NDKB (also named nm23) seems
to be a metastasis suppressor gene and is thought to be
involved in cell migration, proliferation, diﬀerentiation, and
development [25]. MARE1 is also thought to promote poly-
merization of microtubule and to stabilize microﬁlaments
[26]. Downregulation of NDKB and MARE1 in ﬁbroblasts
that are treated with either AS extract or FA would suggest
that there is a reduction in the suppression of migration,
which might be beneﬁcial to cells involved in the wound
healing process. Actin-related protein 2/3 complex subunit
5 (ARPC5) and stathmin (STMN1) were both upregulated
by FA but not by AS extract (Figure 3,c l u s t e rC ) .A R P C sa r e
able to regulate actin dynamics and function as a template
for initiation of new actin ﬁlaments that branch oﬀ an
existing ﬁlament [24]. STMN1 is cytosolic phosphoprotein
and is known to act as microtubule destabilizing protein
that binds free form tubulin, which inhibit microtubule
polymerization [23]. Thus, our results indicate that both AS
e x t r a c ta n dF Aa r ea b l et or e g u l a t ec e l lm o b i l i t yp r o b a b l yb y
controlling microtubule dynamics. Furthermore, it is worth
noting that ARPC5, STMN1, and NDKB have the highest
sequence coverage and score in our mass spectrometric
analysis (Table 1). The migration and wound healing assays
(Figure 5(b)) show that AS extract and FA both promote cell
mobility, and this agrees with the above ﬁndings.
4.5.ProteinsInvolved inCell Growthor Metabolism. CAPNS1
(calpainsmallsubunit1)isabletopromotecellproliferation,
migration, and adhesion [44]. In contrast, LEG1 (galectin-
1) overexpression is thought to inhibit normal mouse
ﬁbroblast growth and increase apoptosis [45]. Interestingly,
we observed that CAPNS1 was upregulated (Figure 3,c l u s t e r
B), while LEG1 was down-regulated (Figure 3, cluster D)
w h e nﬁ b r o b l a s t sw e r et r e a t e dw i t hA Se x t r a c t ;s u c hc o n -
trasting changes in expression between CAPNS1 and LEG1
should be beneﬁcial to the ﬁbroblast wound healing process.
Furthermore, our results also show that, when ﬁbroblasts
were treated with AS extract there were activations of p-
Akt and p-Erk expression (Figures 5(d) and 5(e)). Thus, in
addition to regulating the expression of CAPN1 and LEG1,
AS extract seems to also modulate cell growth via the Erk
and Akt pathways.
The main energy resource of ﬁbroblasts is glycolysis, and
anincreaseinLDHBexpressioninthesecellswouldpromote
propyl hydroxylase activity, which in turn would increase
lactate production and collagen hydroxylation; these eﬀects,
in turn, would help cells tolerate an hypoxia environment
andacceleratethewoundhealingprocess[46].Wefoundthat
both AS extract and FA are able to upregulate the expression
ofTriosephosphate isomerase(TPIS)in ﬁbroblasts(Figure 3,
clusterA),whileonlyASextractcouldactivatetheexpressionEvidence-Based Complementary and Alternative Medicine 13
ofphosphoglyceratekinase(PGK1)andL-lactatedehydroge-
naseBchain(LDHB)(Figure 3,c l ust e rB).Th usw ec o nc l ud e
that AS extract might have greater eﬃcacy in providing
extra energy for wound healing processes by upregulating
g l y c o l y s i s ,w h i c hw o u l dh e l pt op r o t e c tc e l l sf r o mh y p o x i a .
4.6. Potential Molecular Pharmaceutical Mechanism of AS
Extract and FA in Regulating Wound Healing Processes of
Fibroblasts. Taken together, our results revealed a possible
pharmacological wound healing processes induced by the AS
e x t r a c to rF At r e a t m e n to fﬁ b r o b l a s t s( Figure 6). Multiple
factors are likely to be involved in the wound healing
processes induced by either AS extractor FA. Both AS extract
and FA seem to activate the inhibition of ROS production
(PRDXs and PARK7), enhance cell mobility (MARE1 and
NDKB), promote glycolysis (TPIS), increase antiapoptosis
(GSTP1 and TCTP), and regulate calcium ion (ANXA2),
all of which ought to increase the viability of cells during
the wound healing process. The unique pharmacological
functions of AS extract that have been revealed in this
study include enhanced human skin ﬁbroblast proliferation
due to suppression of LEG1 expression, and increased
CAPNS1 expression, and upregulation of PGK1 and LDHB,
which promote glycolysis and activation of the Erk and Akt
signal transduction pathways. Fibroblasts treated with AS
extract seem also to undergo a suppression of apoptosis due
to increased HSPB1 expression. Moreover, an increase in
collagen secretion (TGF-β), calcium ion regulation (VAT1)
and enhanced cell mobility (down-regulation of VIME) also
contribute towards a more eﬃcient wound healing process.
In addition, a number of unique functions of FA have also
been revealed, which include ROS inhibition (GLRX3 and
FRIL) and the promotion of cell mobility by upregulation
of STMN1 and ARPCS and down-regulation of NDKB. The
extra functions of FA mentioned above should reinforce the
healing process associated with ﬁbroblasts as a whole. In
this work, we have described a technological platform that is
able to reveal the underlying principles of a herbal medicine;
namely, how an AS extract and its active component FA
participate in the modulation of wound healing process
associatedwithﬁbroblasts.Theseresultswillhelpandbeneﬁt
the clinical applications of this herbal medicine when it is
used to treat heat burns or traumatic injury to the skin.
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